R
Ruipeng Pet Medical Group
A Shenzhen-based pet medical and beauty care hospital operator
About Ruipeng Pet Medical Group
Ruipeng Pet Medical Group stands as a significant entity in China's burgeoning pet care market, operating a vast network of veterinary hospitals across the country. Established in 1998, the company has grown from a single clinic into a nationwide chain, a trajectory significantly shaped by its founder, Peng Yonghe. Peng, a graduate of China's first veterinary medicine program for pets, leveraged his educational background and early recognition of the growing human-animal bond in China to build the enterprise. His journey reflects a deep-seated commitment to advancing veterinary standards in the country, starting his practice shortly after graduation.
The company's core business revolves around providing comprehensive medical services for pets. This encompasses a wide spectrum of veterinary care, including diagnostics, internal medicine, surgery, and emergency services. Ruipeng serves individual pet owners, a rapidly expanding demographic in China. Its business model is centered on direct-to-consumer services delivered through its extensive chain of owned and franchised hospitals. Revenue is primarily generated from these veterinary services, supplemented by the sale of pet food, medicine, and other related supplies. The company also engages in the broader pet care ecosystem through a dual-brand strategy, with the Ruipeng brand targeting the mass market and the GAVET brand catering to a more high-end clientele.
Ruipeng's service offerings are characterized by their scale and increasing specialization. The group operates general, central, and specialized referral hospitals, creating a tiered system to handle everything from routine check-ups to complex medical cases. This structure allows for a more efficient allocation of resources and expertise. A key aspect of their strategy has been rapid expansion through mergers and acquisitions, consolidating a fragmented market. This has been supported by substantial investment from major industry players, including a strategic partnership with Hillhouse Capital, which merged its own extensive pet hospital assets into the Ruipeng group. This consolidation has created one of the largest pet hospital chains globally by number of locations, positioning Ruipeng as a dominant force in shaping the future of veterinary care in Asia.
Source: Dealroom company dataAt a glance
- Outcome tier
- Unicorn$1–10B valuation tier
News
Open roles
Ruipeng Pet Medical Group in the Shenzhen ecosystem
The Ruipeng Pet Medical Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
River Head Capital
Tencent
Boehringer Ingelheim
Country Garden
Nestlé Health Science
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
197 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ruipeng Pet Medical Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ruipeng Pet Medical Group on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


